Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Epilepsy & Behavior : E&B|March 17, 2026
Novel epilepsy treatments in clinical developmentBoulenouar Mesraoua, Bassel Abou-Khalil, Simona Lattanzi, et al.
Epilepsy Research|January 14, 2021
Complementary and alternative medicine (CAM) for epilepsy treatment in the Middle East and North Africa (MENA) regionBoulenouar Mesraoua, Najib Kissani, Dirk Deleu, et al.
Current Medical Research and Opinion|November 29, 2016
Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from QatarDirk Deleu, Boulenouar Mesraoua, Hisham El Khider, et al.
Current Medical Research and Opinion|May 17, 2018
Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overviewDirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, et al.
Qatar Medical Journal|December 13, 2023
Cigarette smoking as a risk factor for ischaemic stroke in young South Asian male migrants to Qatar: The BRAINS studyFahmi Yousef Khan, Gie Ken-Dror, Paul Ly, et al.
JRSM Cardiovascular Disease|August 28, 2019
Current status of stroke in Qatar: Including data from the BRAINS studyEbrima Jallow, Hassan Al Hail, Thang S Han, et al.
Epilepsy & Behavior : E&B|September 3, 2016
Epilepsy in Qatar: Causes, treatment, and outcomeNaim Haddad, Gayane Melikyan, Hassan Al Hail, et al.
Epilepsy & Behavior : E&B|July 8, 2018
Characteristics of patients with confirmed epilepsy and psychogenic nonepileptic seizures in QatarStacy Schantz Wilkins, Boulenouar Mesraoua, Gonzalo Alarcón Palomo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2012
Prevalence, demographics and clinical characteristics of multiple sclerosis in QatarDirk Deleu, Danial Mir, Ahmed Al Tabouki, et al.
Pageof 3